ATE502911T1 - 4-(c2-6 alkoxy)substituierte chalkone als therapeutische mittel - Google Patents

4-(c2-6 alkoxy)substituierte chalkone als therapeutische mittel

Info

Publication number
ATE502911T1
ATE502911T1 AT02762611T AT02762611T ATE502911T1 AT E502911 T1 ATE502911 T1 AT E502911T1 AT 02762611 T AT02762611 T AT 02762611T AT 02762611 T AT02762611 T AT 02762611T AT E502911 T1 ATE502911 T1 AT E502911T1
Authority
AT
Austria
Prior art keywords
sup
sub
optionally substituted
alkyl
compounds
Prior art date
Application number
AT02762611T
Other languages
English (en)
Inventor
Gerard Andrew Potter
Taeeba Ijaz
Original Assignee
Spear Therapeutics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Spear Therapeutics Ltd filed Critical Spear Therapeutics Ltd
Application granted granted Critical
Publication of ATE502911T1 publication Critical patent/ATE502911T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/76—Ketones containing a keto group bound to a six-membered aromatic ring
    • C07C49/84—Ketones containing a keto group bound to a six-membered aromatic ring containing ether groups, groups, groups, or groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/27—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation
    • C07C45/29—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation of hydroxy groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
    • C07C45/68—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
    • C07C45/70—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form
    • C07C45/71—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form being hydroxy groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
    • C07C45/68—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
    • C07C45/72—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction of compounds containing >C = O groups with the same or other compounds containing >C = O groups
    • C07C45/74—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction of compounds containing >C = O groups with the same or other compounds containing >C = O groups combined with dehydration

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT02762611T 2001-10-03 2002-09-30 4-(c2-6 alkoxy)substituierte chalkone als therapeutische mittel ATE502911T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0123780.9A GB0123780D0 (en) 2001-10-03 2001-10-03 Substituted chalcones as therapeutic agents
PCT/GB2002/004462 WO2003029176A1 (en) 2001-10-03 2002-09-30 4-(c2-6alkoxy)-substituted chalcones as therapeutic agents

Publications (1)

Publication Number Publication Date
ATE502911T1 true ATE502911T1 (de) 2011-04-15

Family

ID=9923191

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02762611T ATE502911T1 (de) 2001-10-03 2002-09-30 4-(c2-6 alkoxy)substituierte chalkone als therapeutische mittel

Country Status (8)

Country Link
US (1) US7112698B2 (de)
EP (1) EP1432669B1 (de)
AT (1) ATE502911T1 (de)
CA (1) CA2462228C (de)
DE (1) DE60239548D1 (de)
ES (1) ES2364312T3 (de)
GB (1) GB0123780D0 (de)
WO (1) WO2003029176A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080266261A1 (en) * 2007-04-25 2008-10-30 Idzik Jacek S Keystroke Error Correction Method
GB0907551D0 (en) 2009-05-01 2009-06-10 Univ Dundee Treatment or prophylaxis of proliferative conditions
KR20200118827A (ko) 2018-02-02 2020-10-16 마베릭스 온콜로지, 잉크. 젬시타빈 모노포스페이트의 소분자 약물 컨쥬게이트
US11746104B2 (en) 2019-06-13 2023-09-05 Qatar University Chalcone-based chemotherapeutic compound for triple negative breast cancer

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4279930A (en) 1978-10-10 1981-07-21 The Upjohn Company Process for treating inflammation
JPS6176433A (ja) 1984-09-21 1986-04-18 Toyobo Co Ltd 新規なカルコン誘導体
LU86715A1 (fr) 1986-12-16 1988-07-14 Oreal Composition cosmetique contenant des derives hydroxyles de chalcone et son utilisation pour la protection de la peau et des cheveux contre les radiations lumineuses,nouveaux derives hydroxyles de chalcone utilises et leur procede de preparation
JPH02142717A (ja) * 1988-11-22 1990-05-31 Kanebo Ltd 養毛化粧料
JPH05246932A (ja) 1992-03-04 1993-09-24 Nippon High Potsukusu:Kk ３，４−ジヒドロキシカルコン誘導体
US5430062A (en) 1992-05-21 1995-07-04 Research Corporation Technologies, Inc. Stilbene derivatives as anticancer agents
JPH09501920A (ja) 1993-08-19 1997-02-25 ワーナー−ランバート・コンパニー 非ペプチドエンドセリンアンタゴニスト▲ｉ▼
JPH08188546A (ja) 1995-01-04 1996-07-23 Kyowa Hakko Kogyo Co Ltd カルコン誘導体
GB9519490D0 (en) 1995-09-25 1995-11-29 Melvin William T Use of a cytochrome P450 enzyme in tumour cells as a marker and target
EP0996432A2 (de) 1997-06-26 2000-05-03 Statens Seruminstitut Biologisch-wirksame 1,3-bis-aromatische-prop-2-en-1-on, 1,3-bis-aromatische-propan-1-on, and 1,3-bis-aromatische-prop-2-yn-1-on
DE69918950T2 (de) 1998-02-06 2005-07-28 De Montfort University Durch hydroxylierung aktivierte medikamentvorstufen
GB9802522D0 (en) 1998-02-06 1998-04-01 Montford University De Hydroxylation activated prodrugs
EP1242352A2 (de) 1999-12-23 2002-09-25 University Of Georgia Research Foundation, Inc. Chalcone und ihre analoge als hemmende wirkstoffe für angiogenese und verwandte krankheiten
GB0007401D0 (en) * 2000-03-27 2000-05-17 Cancer Res Campaign Tech Substituted chalcones as therapeeutic compounds

Also Published As

Publication number Publication date
EP1432669B1 (de) 2011-03-23
EP1432669A1 (de) 2004-06-30
US7112698B2 (en) 2006-09-26
WO2003029176A1 (en) 2003-04-10
ES2364312T3 (es) 2011-08-31
CA2462228A1 (en) 2003-04-10
CA2462228C (en) 2011-03-15
US20040259957A1 (en) 2004-12-23
GB0123780D0 (en) 2001-11-21
DE60239548D1 (de) 2011-05-05

Similar Documents

Publication Publication Date Title
ES2734209T3 (es) Inhibidores de KDM1A para el tratamiento de enfermedades
TR200400541T4 (tr) Terapide faydalı tropan türevleri.
NO307929B1 (no) Naftylforbindelser, anvendelse av disse for fremstilling av et farmasøytisk preparat, mellomprodukter, sammensetninger inneholdende disse forbindelser eller mellomprodukter, samt fremgangsmÕte for fremstilling av forbindelsene
WO2002030879A3 (en) Carbamic acid compounds comprising a sulfonamide linkage as hdac inhibitors
CY1107519T1 (el) Yποκατεστημενες χαλκονες ως θepαπευτικες ενωσεις
ATE253545T1 (de) Biarylessigsäure-derivate und ihre verwendung als cox-2 inhibitoren
EA200400054A1 (ru) Замещенные нафтилиндольные производные в качестве ингибиторов ингибитора активатора плазминогена типа 1 (pai-1)
AR036100A1 (es) Derivados de naftil benzofurano sustituidos, composiciones farmaceuticas y el uso de dichos derivados para la manufactura de medicamentos que son inhibidores del inhibidor-1 activador de plasminogeno (pai-1)
NO20034011D0 (no) Steroider som agonister for FXR
ATE307810T1 (de) Imidazol-2-carbonsäureamid derivate als raf- kinase-inhibitoren
CY1110468T1 (el) Χρηση αναστολεων γλυκοσιδασης για μια θεραπεια της κυστικης ινωσεως
BR0206955A (pt) Ligantes de receptores de canabinóides
ATE232520T1 (de) Imidazolidin-4-on derivate verwendbar als antikrebsmittel
EA200802173A1 (ru) Производные терфенила для лечения болезни альцгеймера
DE60131160D1 (de) Caspase-inhibitoren und ihre verwendungen
TR199902367T2 (xx) 16-Hidroksi-11-(ikameli fenil)-estra-4,9-dien t�revleri.
NO20040589L (no) Arylsulfonylderivater med 5-HT6 reseptor affinitet.
SE0402925D0 (sv) Novel Compounds
RU2010115337A (ru) Трициклические гетероциклические производные
DE69628246D1 (de) Naphthyl- und Dihydronaphthylverbindungen als Arzneimittel
JP2011510072A5 (de)
DE60239548D1 (de) 4-(c2-6 alkoxy)substituierte chalkone als therapeutische mittel
EA200701780A1 (ru) Противоопухолевое средство
ATE457306T1 (de) 4-aryl substituierte chinole und analoga als therapeutische wirkstoffe
PT1412332E (pt) Derivados de quinolina e sua utilizacao como agentes antitumorais

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties